Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-24-033149
Filing Date
2024-03-12
Accepted
2024-03-11 21:05:28
Documents
122
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F blte-20231231x20f.htm   iXBRL 20-F 3421973
2 EXHIBIT 2.6 blte-20231231xex2d6.htm EX-2.6 160387
3 EXHIBIT 8.1 blte-20231231xex8d1.htm EX-8.1 5241
4 EXHIBIT 11.2 blte-20231231xex11d2.htm EX-11.2 64370
5 EXHIBIT 12.1 blte-20231231xex12d1.htm EX-12.1 11102
6 EXHIBIT 12.2 blte-20231231xex12d2.htm EX-12.2 10845
7 EXHIBIT 13.1 blte-20231231xex13d1.htm EX-13.1 7364
8 EXHIBIT 13.2 blte-20231231xex13d2.htm EX-13.2 7771
9 EXHIBIT 23.1 blte-20231231xex23d1.htm EX-23.1 3251
10 EXHIBIT 23.2 blte-20231231xex23d2.htm EX-23.2 3744
11 EXHIBIT 23.3 blte-20231231xex23d3.htm EX-23.3 5927
12 EXHIBIT 97.1 blte-20231231xex97d1.htm EX-97.1 46571
18 GRAPHIC blte-20231231x20f002.jpg GRAPHIC 38101
19 GRAPHIC blte-20231231x20f024.jpg GRAPHIC 18279
20 GRAPHIC blte-20231231x20f003.jpg GRAPHIC 14418
21 GRAPHIC blte-20231231x20f004.jpg GRAPHIC 101731
22 GRAPHIC blte-20231231x20f005.jpg GRAPHIC 59296
23 GRAPHIC blte-20231231x20f006.jpg GRAPHIC 69355
24 GRAPHIC blte-20231231x20f007.jpg GRAPHIC 62998
25 GRAPHIC blte-20231231x20f008.jpg GRAPHIC 52542
26 GRAPHIC blte-20231231x20f009.jpg GRAPHIC 32330
27 GRAPHIC blte-20231231x20f010.jpg GRAPHIC 65199
28 GRAPHIC blte-20231231x20f011.jpg GRAPHIC 36532
29 GRAPHIC blte-20231231x20f014.jpg GRAPHIC 38446
30 GRAPHIC blte-20231231x20f015.jpg GRAPHIC 33510
31 GRAPHIC blte-20231231x20f016.jpg GRAPHIC 41436
32 GRAPHIC blte-20231231x20f023.jpg GRAPHIC 8242
33 GRAPHIC blte-20231231xex23d3001.jpg GRAPHIC 6726
34 GRAPHIC blte-20231231xex23d1001.jpg GRAPHIC 5031
35 GRAPHIC blte-20231231xex23d2001.jpg GRAPHIC 14652
  Complete submission text file 0001104659-24-033149.txt   13134777

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA blte-20231231.xsd EX-101.SCH 69778
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE blte-20231231_cal.xml EX-101.CAL 57348
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blte-20231231_def.xml EX-101.DEF 322509
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE blte-20231231_lab.xml EX-101.LAB 605412
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blte-20231231_pre.xml EX-101.PRE 500772
124 EXTRACTED XBRL INSTANCE DOCUMENT blte-20231231x20f_htm.xml XML 1539089
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Filer) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41359 | Film No.: 24740013
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)